OBJECTIVE: The study presents data on the 3-month prevalences of postpartum anxiety disorders (PAD) and postpartum depressive disorders (PDD) and their comorbidity in a German community sample. Associations with sociodemographic variables and previous history of psychopathology were analysed. METHOD: Data were gathered in a longitudinal study over the first 3 months postpartum. In a two-stage screening procedure, a population-based representative sample of 1024 postpartum women was assessed for symptoms of anxiety and depression using DSM-IV-based screening instruments. RESULTS: The estimated rates of DSM-IV disorders were 11.1% for PAD and 6.1% for PDD. Comorbidity was found in 2.1%. The rate for PAD with postpartum onset was 2.2% and for PDD 4.6%. Young mothers and mothers with a low education level had a heightened risk of developing depression following delivery. CONCLUSION: Because of the clinical relevance of PAD, controlled studies and specialized programmes for prevention and treatment are urgently required.
OBJECTIVE: The study presents data on the 3-month prevalences of postpartum anxiety disorders (PAD) and postpartum depressive disorders (PDD) and their comorbidity in a German community sample. Associations with sociodemographic variables and previous history of psychopathology were analysed. METHOD: Data were gathered in a longitudinal study over the first 3 months postpartum. In a two-stage screening procedure, a population-based representative sample of 1024 postpartum women was assessed for symptoms of anxiety and depression using DSM-IV-based screening instruments. RESULTS: The estimated rates of DSM-IV disorders were 11.1% for PAD and 6.1% for PDD. Comorbidity was found in 2.1%. The rate for PAD with postpartum onset was 2.2% and for PDD 4.6%. Young mothers and mothers with a low education level had a heightened risk of developing depression following delivery. CONCLUSION: Because of the clinical relevance of PAD, controlled studies and specialized programmes for prevention and treatment are urgently required.
Authors: S K Williams; J S Barber; A W Jamieson-Drake; J A Enns; L B Townsend; C H Walker; J M Johns Journal: J Neuroendocrinol Date: 2012-04 Impact factor: 3.627
Authors: Samantha Meltzer-Brody; Stephanie Zerwas; Jane Leserman; Ann Von Holle; Taylor Regis; Cynthia Bulik Journal: J Womens Health (Larchmt) Date: 2011-06 Impact factor: 2.681
Authors: Alison E Hipwell; Stephanie D Stepp; Eydie L Moses-Kolko; Shuangyan Xiong; Elena Paul; Natalie Merrick; Samantha McClelland; Danielle Verble; Kate Keenan Journal: Arch Womens Ment Health Date: 2016-03-12 Impact factor: 3.633